Neurocrine Biosciences Inc
2021 Q1 - 2025 Q4 (19 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 661 | 0.0% | 4,661 | 12/31/2025 |
| 2025 Q3 | 10/29/2025 | 654 | 0.0% | 4,661 | 9/30/2025 |
| 2025 Q2 | 7/23/2025 | 586 | 0.0% | 4,661 | 6/30/2025 |
| 2025 Q1 | 5/12/2025 | 516 | 0.0% | 4,661 | 3/31/2025 |
| 2024 Q4 | 2/11/2025 | 727 | 0.0% | 5,324 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 656 | 0.0% | 5,696 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 1,026 | 0.0% | 7,450 | 6/30/2024 |
| 2024 Q1 | 4/19/2024 | 992 | 0.0% | 7,450 | 3/31/2024 |
| 2023 Q4 | 2/6/2024 | 982 | 0.0% | 7,450 | 12/31/2023 |
| 2023 Q3 | 10/24/2023 | 838 | 0.0% | 7,450 | 9/30/2023 |
| 2023 Q2 | 7/11/2023 | 703 | 0.0% | 7,450 | 6/30/2023 |
| 2023 Q1 | 4/20/2023 | 754 | 0.0% | 7,450 | 3/31/2023 |
| 2022 Q4 | 1/18/2023 | 890 | 0.0% | 7,450 | 12/31/2022 |
| 2022 Q2 | 8/1/2022 | 687 | 0.0% | 7,049 | 6/30/2022 |
| 2022 Q1 | 4/11/2022 | 661 | 0.0% | 7,049 | 3/31/2022 |
| 2021 Q4 | 2/9/2022 | 600 | 0.0% | 7,049 | 12/31/2021 |
| 2021 Q3 | 10/29/2021 | 672 | 0.0% | 7,049 | 9/30/2021 |
| 2021 Q2 | 7/13/2021 | 687 | 0.0% | 7,049 | 6/30/2021 |
| 2021 Q1 | 5/10/2021 | 686 | 0.0% | 7,049 | 3/31/2021 |